Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 13/01/2012
PIL Cozaar - Comp 50/12.5mg, 100/12.5mg, 100/25mg Film-Coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 28/09/2011 and displayed until 13/01/2012
Reasons for adding or updating:
  • Extra statutory information
Updated on 04/08/2010 and displayed until 28/09/2011
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to Further Information section
  • Change to drug interactions
Updated on 19/01/2010 and displayed until 04/08/2010
Reasons for adding or updating:
  • Change to storage instructions
  • Change to information about pregnancy or lactation
  • Change to name of manufacturer
  • Change to packaging
  • Change to warnings or special precautions for use
Updated on 19/02/2009 and displayed until 19/01/2010
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Individual presentations superseded by joint PIL
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Changes to therapeutic indications
Updated on 27/05/2008 and displayed until 19/02/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 25/01/2007 and displayed until 27/05/2008
Reasons for adding or updating:
  • Change to drug interactions
Updated on 31/10/2005 and displayed until 25/01/2007
Reasons for adding or updating:
  • Change of trade or generic name
Updated on 26/01/2005 and displayed until 31/10/2005
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 23/12/2004 and displayed until 26/01/2005
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
Updated on 25/09/2003 and displayed until 23/12/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 18/07/2001 and displayed until 25/09/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  hydrochlorothiazide
  losartan potassium